Global Next Generation Tumor Genetic Testing Market Research Report 2026(Status and Outlook)
The global Next Generation Tumor Genetic Testing market size was estimated at USD 7850.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Next Generation Tumor Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Next Generation Tumor Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Next Generation Tumor Genetic Testing market.
Global Next Generation Tumor Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Tumor Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Next Generation Tumor Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Next Generation Tumor Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Next Generation Tumor Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Next Generation Tumor Genetic Testing market.
Global Next Generation Tumor Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Next Generation Tumor Genetic Testing Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Tumor Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Next Generation Tumor Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Next Generation Tumor Genetic Testing
1.2 Key Market Segments
1.2.1 Next Generation Tumor Genetic Testing Segment by Type
1.2.2 Next Generation Tumor Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION TUMOR GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION TUMOR GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Next Generation Tumor Genetic Testing Product Life Cycle
3.3 Global Next Generation Tumor Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Next Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Next Generation Tumor Genetic Testing Market Competitive Situation and Trends
3.6.1 Next Generation Tumor Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Tumor Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION TUMOR GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Next Generation Tumor Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION TUMOR GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Next Generation Tumor Genetic Testing Market Porter's Five Forces Analysis
6 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Tumor Genetic Testing Market by Type (2020-2025)
6.3 Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Tumor Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
8 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Next Generation Tumor Genetic Testing Market Size by Region
8.1.1 Global Next Generation Tumor Genetic Testing Market Size by Region
8.1.2 Global Next Generation Tumor Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Next Generation Tumor Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Tumor Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Tumor Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Tumor Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Tumor Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Devyser
9.1.1 Devyser Basic Information
9.1.2 Devyser Next Generation Tumor Genetic Testing Product Overview
9.1.3 Devyser Next Generation Tumor Genetic Testing Product Market Performance
9.1.4 Devyser SWOT Analysis
9.1.5 Devyser Business Overview
9.1.6 Devyser Recent Developments
9.2 Agendia
9.2.1 Agendia Basic Information
9.2.2 Agendia Next Generation Tumor Genetic Testing Product Overview
9.2.3 Agendia Next Generation Tumor Genetic Testing Product Market Performance
9.2.4 Agendia SWOT Analysis
9.2.5 Agendia Business Overview
9.2.6 Agendia Recent Developments
9.3 Illumina
9.3.1 Illumina Basic Information
9.3.2 Illumina Next Generation Tumor Genetic Testing Product Overview
9.3.3 Illumina Next Generation Tumor Genetic Testing Product Market Performance
9.3.4 Illumina SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Personal Genome Diagnostics
9.4.1 Personal Genome Diagnostics Basic Information
9.4.2 Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Overview
9.4.3 Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Market Performance
9.4.4 Personal Genome Diagnostics Business Overview
9.4.5 Personal Genome Diagnostics Recent Developments
9.5 Veracyte
9.5.1 Veracyte Basic Information
9.5.2 Veracyte Next Generation Tumor Genetic Testing Product Overview
9.5.3 Veracyte Next Generation Tumor Genetic Testing Product Market Performance
9.5.4 Veracyte Business Overview
9.5.5 Veracyte Recent Developments
9.6 Pacific Biosciences of California
9.6.1 Pacific Biosciences of California Basic Information
9.6.2 Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Overview
9.6.3 Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Market Performance
9.6.4 Pacific Biosciences of California Business Overview
9.6.5 Pacific Biosciences of California Recent Developments
9.7 Qiagen
9.7.1 Qiagen Basic Information
9.7.2 Qiagen Next Generation Tumor Genetic Testing Product Overview
9.7.3 Qiagen Next Generation Tumor Genetic Testing Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Agilent Technologies
9.8.1 Agilent Technologies Basic Information
9.8.2 Agilent Technologies Next Generation Tumor Genetic Testing Product Overview
9.8.3 Agilent Technologies Next Generation Tumor Genetic Testing Product Market Performance
9.8.4 Agilent Technologies Business Overview
9.8.5 Agilent Technologies Recent Developments
9.9 Natera
9.9.1 Natera Basic Information
9.9.2 Natera Next Generation Tumor Genetic Testing Product Overview
9.9.3 Natera Next Generation Tumor Genetic Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Bio Rad Laboratories
9.10.1 Bio Rad Laboratories Basic Information
9.10.2 Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Overview
9.10.3 Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Market Performance
9.10.4 Bio Rad Laboratories Business Overview
9.10.5 Bio Rad Laboratories Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Basic Information
9.11.2 Myriad Genetics Next Generation Tumor Genetic Testing Product Overview
9.11.3 Myriad Genetics Next Generation Tumor Genetic Testing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
10 NEXT GENERATION TUMOR GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Next Generation Tumor Genetic Testing Market Size Forecast
10.2 Global Next Generation Tumor Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Tumor Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Tumor Genetic Testing Market Size Forecast by Region
10.2.4 South America Next Generation Tumor Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Next Generation Tumor Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Next Generation Tumor Genetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Next Generation Tumor Genetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Next Generation Tumor Genetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Next Generation Tumor Genetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Next Generation Tumor Genetic Testing
1.2 Key Market Segments
1.2.1 Next Generation Tumor Genetic Testing Segment by Type
1.2.2 Next Generation Tumor Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION TUMOR GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION TUMOR GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Next Generation Tumor Genetic Testing Product Life Cycle
3.3 Global Next Generation Tumor Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Next Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Next Generation Tumor Genetic Testing Market Competitive Situation and Trends
3.6.1 Next Generation Tumor Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Tumor Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION TUMOR GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Next Generation Tumor Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION TUMOR GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Next Generation Tumor Genetic Testing Market Porter's Five Forces Analysis
6 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Tumor Genetic Testing Market by Type (2020-2025)
6.3 Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Tumor Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
8 NEXT GENERATION TUMOR GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Next Generation Tumor Genetic Testing Market Size by Region
8.1.1 Global Next Generation Tumor Genetic Testing Market Size by Region
8.1.2 Global Next Generation Tumor Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Next Generation Tumor Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Tumor Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Tumor Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Tumor Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Tumor Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Devyser
9.1.1 Devyser Basic Information
9.1.2 Devyser Next Generation Tumor Genetic Testing Product Overview
9.1.3 Devyser Next Generation Tumor Genetic Testing Product Market Performance
9.1.4 Devyser SWOT Analysis
9.1.5 Devyser Business Overview
9.1.6 Devyser Recent Developments
9.2 Agendia
9.2.1 Agendia Basic Information
9.2.2 Agendia Next Generation Tumor Genetic Testing Product Overview
9.2.3 Agendia Next Generation Tumor Genetic Testing Product Market Performance
9.2.4 Agendia SWOT Analysis
9.2.5 Agendia Business Overview
9.2.6 Agendia Recent Developments
9.3 Illumina
9.3.1 Illumina Basic Information
9.3.2 Illumina Next Generation Tumor Genetic Testing Product Overview
9.3.3 Illumina Next Generation Tumor Genetic Testing Product Market Performance
9.3.4 Illumina SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Personal Genome Diagnostics
9.4.1 Personal Genome Diagnostics Basic Information
9.4.2 Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Overview
9.4.3 Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Market Performance
9.4.4 Personal Genome Diagnostics Business Overview
9.4.5 Personal Genome Diagnostics Recent Developments
9.5 Veracyte
9.5.1 Veracyte Basic Information
9.5.2 Veracyte Next Generation Tumor Genetic Testing Product Overview
9.5.3 Veracyte Next Generation Tumor Genetic Testing Product Market Performance
9.5.4 Veracyte Business Overview
9.5.5 Veracyte Recent Developments
9.6 Pacific Biosciences of California
9.6.1 Pacific Biosciences of California Basic Information
9.6.2 Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Overview
9.6.3 Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Market Performance
9.6.4 Pacific Biosciences of California Business Overview
9.6.5 Pacific Biosciences of California Recent Developments
9.7 Qiagen
9.7.1 Qiagen Basic Information
9.7.2 Qiagen Next Generation Tumor Genetic Testing Product Overview
9.7.3 Qiagen Next Generation Tumor Genetic Testing Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Agilent Technologies
9.8.1 Agilent Technologies Basic Information
9.8.2 Agilent Technologies Next Generation Tumor Genetic Testing Product Overview
9.8.3 Agilent Technologies Next Generation Tumor Genetic Testing Product Market Performance
9.8.4 Agilent Technologies Business Overview
9.8.5 Agilent Technologies Recent Developments
9.9 Natera
9.9.1 Natera Basic Information
9.9.2 Natera Next Generation Tumor Genetic Testing Product Overview
9.9.3 Natera Next Generation Tumor Genetic Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Bio Rad Laboratories
9.10.1 Bio Rad Laboratories Basic Information
9.10.2 Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Overview
9.10.3 Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Market Performance
9.10.4 Bio Rad Laboratories Business Overview
9.10.5 Bio Rad Laboratories Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Basic Information
9.11.2 Myriad Genetics Next Generation Tumor Genetic Testing Product Overview
9.11.3 Myriad Genetics Next Generation Tumor Genetic Testing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
10 NEXT GENERATION TUMOR GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Next Generation Tumor Genetic Testing Market Size Forecast
10.2 Global Next Generation Tumor Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Tumor Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Tumor Genetic Testing Market Size Forecast by Region
10.2.4 South America Next Generation Tumor Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Next Generation Tumor Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Next Generation Tumor Genetic Testing Market Forecast by Type (2026-2035)
11.1.1 Global Next Generation Tumor Genetic Testing Market Size Forecast by Type (2026-2035)
11.2 Global Next Generation Tumor Genetic Testing Market Forecast by Application (2026-2035)
11.2.1 Global Next Generation Tumor Genetic Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Next Generation Tumor Genetic Testing Market Size by Type (M USD)
Table 4. Global Next Generation Tumor Genetic Testing Market Size by Application
Table 5. Next Generation Tumor Genetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Next Generation Tumor Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Next Generation Tumor Genetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Tumor Genetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Next Generation Tumor Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Next Generation Tumor Genetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Next Generation Tumor Genetic Testing Market Size by Type (M USD)
Table 22. Global Next Generation Tumor Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Next Generation Tumor Genetic Testing Market Share by Type (2020-2025)
Table 24. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Next Generation Tumor Genetic Testing Market Size by Application
Table 26. Global Next Generation Tumor Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Next Generation Tumor Genetic Testing Market Share by Application (2020-2025)
Table 28. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Next Generation Tumor Genetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Devyser Basic Information
Table 37. Devyser Next Generation Tumor Genetic Testing Product Overview
Table 38. Devyser Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Devyser SWOT Analysis
Table 40. Devyser Business Overview
Table 41. Devyser Recent Developments
Table 42. Agendia Basic Information
Table 43. Agendia Next Generation Tumor Genetic Testing Product Overview
Table 44. Agendia Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Agendia SWOT Analysis
Table 46. Agendia Business Overview
Table 47. Agendia Recent Developments
Table 48. Illumina Basic Information
Table 49. Illumina Next Generation Tumor Genetic Testing Product Overview
Table 50. Illumina Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Illumina SWOT Analysis
Table 52. Illumina Business Overview
Table 53. Illumina Recent Developments
Table 54. Personal Genome Diagnostics Basic Information
Table 55. Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Overview
Table 56. Personal Genome Diagnostics Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Personal Genome Diagnostics Business Overview
Table 58. Personal Genome Diagnostics Recent Developments
Table 59. Veracyte Basic Information
Table 60. Veracyte Next Generation Tumor Genetic Testing Product Overview
Table 61. Veracyte Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Veracyte Business Overview
Table 63. Veracyte Recent Developments
Table 64. Pacific Biosciences of California Basic Information
Table 65. Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Overview
Table 66. Pacific Biosciences of California Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Pacific Biosciences of California Business Overview
Table 68. Pacific Biosciences of California Recent Developments
Table 69. Qiagen Basic Information
Table 70. Qiagen Next Generation Tumor Genetic Testing Product Overview
Table 71. Qiagen Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Qiagen Business Overview
Table 73. Qiagen Recent Developments
Table 74. Agilent Technologies Basic Information
Table 75. Agilent Technologies Next Generation Tumor Genetic Testing Product Overview
Table 76. Agilent Technologies Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Recent Developments
Table 79. Natera Basic Information
Table 80. Natera Next Generation Tumor Genetic Testing Product Overview
Table 81. Natera Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Natera Business Overview
Table 83. Natera Recent Developments
Table 84. Bio Rad Laboratories Basic Information
Table 85. Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Overview
Table 86. Bio Rad Laboratories Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Bio Rad Laboratories Business Overview
Table 88. Bio Rad Laboratories Recent Developments
Table 89. Myriad Genetics Basic Information
Table 90. Myriad Genetics Next Generation Tumor Genetic Testing Product Overview
Table 91. Myriad Genetics Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Recent Developments
Table 94. Global Next Generation Tumor Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 95. North America Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Europe Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Asia Pacific Next Generation Tumor Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Middle East and Africa Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Global Next Generation Tumor Genetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 101. Global Next Generation Tumor Genetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Next Generation Tumor Genetic Testing Market Size by Type (M USD)
Table 4. Global Next Generation Tumor Genetic Testing Market Size by Application
Table 5. Next Generation Tumor Genetic Testing Market Size Comparison by Region (M USD)
Table 6. Global Next Generation Tumor Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Next Generation Tumor Genetic Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Tumor Genetic Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Next Generation Tumor Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Next Generation Tumor Genetic Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Next Generation Tumor Genetic Testing Market Size by Type (M USD)
Table 22. Global Next Generation Tumor Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Next Generation Tumor Genetic Testing Market Share by Type (2020-2025)
Table 24. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Next Generation Tumor Genetic Testing Market Size by Application
Table 26. Global Next Generation Tumor Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Next Generation Tumor Genetic Testing Market Share by Application (2020-2025)
Table 28. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Next Generation Tumor Genetic Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Next Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Next Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Devyser Basic Information
Table 37. Devyser Next Generation Tumor Genetic Testing Product Overview
Table 38. Devyser Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Devyser SWOT Analysis
Table 40. Devyser Business Overview
Table 41. Devyser Recent Developments
Table 42. Agendia Basic Information
Table 43. Agendia Next Generation Tumor Genetic Testing Product Overview
Table 44. Agendia Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Agendia SWOT Analysis
Table 46. Agendia Business Overview
Table 47. Agendia Recent Developments
Table 48. Illumina Basic Information
Table 49. Illumina Next Generation Tumor Genetic Testing Product Overview
Table 50. Illumina Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Illumina SWOT Analysis
Table 52. Illumina Business Overview
Table 53. Illumina Recent Developments
Table 54. Personal Genome Diagnostics Basic Information
Table 55. Personal Genome Diagnostics Next Generation Tumor Genetic Testing Product Overview
Table 56. Personal Genome Diagnostics Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Personal Genome Diagnostics Business Overview
Table 58. Personal Genome Diagnostics Recent Developments
Table 59. Veracyte Basic Information
Table 60. Veracyte Next Generation Tumor Genetic Testing Product Overview
Table 61. Veracyte Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Veracyte Business Overview
Table 63. Veracyte Recent Developments
Table 64. Pacific Biosciences of California Basic Information
Table 65. Pacific Biosciences of California Next Generation Tumor Genetic Testing Product Overview
Table 66. Pacific Biosciences of California Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Pacific Biosciences of California Business Overview
Table 68. Pacific Biosciences of California Recent Developments
Table 69. Qiagen Basic Information
Table 70. Qiagen Next Generation Tumor Genetic Testing Product Overview
Table 71. Qiagen Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Qiagen Business Overview
Table 73. Qiagen Recent Developments
Table 74. Agilent Technologies Basic Information
Table 75. Agilent Technologies Next Generation Tumor Genetic Testing Product Overview
Table 76. Agilent Technologies Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Recent Developments
Table 79. Natera Basic Information
Table 80. Natera Next Generation Tumor Genetic Testing Product Overview
Table 81. Natera Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Natera Business Overview
Table 83. Natera Recent Developments
Table 84. Bio Rad Laboratories Basic Information
Table 85. Bio Rad Laboratories Next Generation Tumor Genetic Testing Product Overview
Table 86. Bio Rad Laboratories Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Bio Rad Laboratories Business Overview
Table 88. Bio Rad Laboratories Recent Developments
Table 89. Myriad Genetics Basic Information
Table 90. Myriad Genetics Next Generation Tumor Genetic Testing Product Overview
Table 91. Myriad Genetics Next Generation Tumor Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Recent Developments
Table 94. Global Next Generation Tumor Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 95. North America Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Europe Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Asia Pacific Next Generation Tumor Genetic Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Middle East and Africa Next Generation Tumor Genetic Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Global Next Generation Tumor Genetic Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 101. Global Next Generation Tumor Genetic Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Next Generation Tumor Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Tumor Genetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Next Generation Tumor Genetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Next Generation Tumor Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Next Generation Tumor Genetic Testing Product Life Cycle
Figure 12. Global Next Generation Tumor Genetic Testing Revenue Share by Company in 2025
Figure 13. Next Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Next Generation Tumor Genetic Testing Revenue in 2025
Figure 15. Value Chain Map of Next Generation Tumor Genetic Testing
Figure 16. Global Next Generation Tumor Genetic Testing Market PEST Analysis
Figure 17. Global Next Generation Tumor Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Next Generation Tumor Genetic Testing Market Share by Type
Figure 20. Market Share of Next Generation Tumor Genetic Testing by Type (2020-2025)
Figure 21. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Next Generation Tumor Genetic Testing Market Share by Application
Figure 24. Global Next Generation Tumor Genetic Testing Market Share by Application (2020-2025)
Figure 25. Global Next Generation Tumor Genetic Testing Market Share by Application in 2024
Figure 26. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Next Generation Tumor Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Next Generation Tumor Genetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Next Generation Tumor Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Next Generation Tumor Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Next Generation Tumor Genetic Testing Market Share by Country in 2024
Figure 35. Germany Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Next Generation Tumor Genetic Testing Market Size Market Share by Region in 2024
Figure 42. China Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Next Generation Tumor Genetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Next Generation Tumor Genetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Next Generation Tumor Genetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Next Generation Tumor Genetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Next Generation Tumor Genetic Testing Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Next Generation Tumor Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Tumor Genetic Testing Market Size (M USD), 2025-2035
Figure 5. Global Next Generation Tumor Genetic Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Next Generation Tumor Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Next Generation Tumor Genetic Testing Product Life Cycle
Figure 12. Global Next Generation Tumor Genetic Testing Revenue Share by Company in 2025
Figure 13. Next Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Next Generation Tumor Genetic Testing Revenue in 2025
Figure 15. Value Chain Map of Next Generation Tumor Genetic Testing
Figure 16. Global Next Generation Tumor Genetic Testing Market PEST Analysis
Figure 17. Global Next Generation Tumor Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Next Generation Tumor Genetic Testing Market Share by Type
Figure 20. Market Share of Next Generation Tumor Genetic Testing by Type (2020-2025)
Figure 21. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Next Generation Tumor Genetic Testing Market Share by Application
Figure 24. Global Next Generation Tumor Genetic Testing Market Share by Application (2020-2025)
Figure 25. Global Next Generation Tumor Genetic Testing Market Share by Application in 2024
Figure 26. Global Next Generation Tumor Genetic Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Next Generation Tumor Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Next Generation Tumor Genetic Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Next Generation Tumor Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Next Generation Tumor Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Next Generation Tumor Genetic Testing Market Share by Country in 2024
Figure 35. Germany Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Next Generation Tumor Genetic Testing Market Size Market Share by Region in 2024
Figure 42. China Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 48. South America Next Generation Tumor Genetic Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Next Generation Tumor Genetic Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Next Generation Tumor Genetic Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Next Generation Tumor Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Next Generation Tumor Genetic Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Next Generation Tumor Genetic Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Next Generation Tumor Genetic Testing Market Share Forecast by Application (2026-2035)
